Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate

References

• Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9:709 - 15; http://dx.doi.org/10.1016/j.autrev.2010.06.009; PMID: 20601202
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911 - 30; http://dx.doi.org/10.1210/jc.2011-0385; PMID: 21646368
   PubMed Web of Science ®Google Scholar
• Hollis BW. Short-term and long-term consequences and concerns regarding valid assessment of vitamin D deficiency: comparison of recent food supplementation and clinical guidance reports. Curr Opin Clin Nutr Metab Care 2011; 14:598 - 604; http://dx.doi.org/10.1097/MCO.0b013e32834be798; PMID: 21934610
   PubMed Web of Science ®Google Scholar
• IARC Working Group Report 5: Vitamin D and Cancer. IARC, Lyon, France. 2008.
   Google Scholar
• Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53 - 8; http://dx.doi.org/10.1210/jc.2010-2704; PMID: 21118827
   PubMed Web of Science ®Google Scholar
• Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, et al. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep)(183), 1-420. (Prepared by Tufts Evidence-based Practice Center under Contract No. 290-2007-10055-I). AHRQ Publication No. 09-E015, Rockville, MD: Agency for Healthcare Research and Quality. August 2009. http://www.ahrq.gov/downloads/pub/evidence/pdf/vitadcal/vitadcal.pdf)
   Google Scholar
• Helzlsouer KJ, VDPP Steering Committee. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172:4 - 9; http://dx.doi.org/10.1093/aje/kwq119; PMID: 20562193
   PubMed Web of Science ®Google Scholar
• Grant WB. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 2010; 101:130 - 6; http://dx.doi.org/10.1016/j.jphotobiol.2010.04.008; PMID: 20570169
   PubMed Web of Science ®Google Scholar
• Grant WB. Ecological studies of the UVB-vitamin D-cancer hypothesis. [review] Anticancer Res 2012; 32:223 - 36; PMID: 22213311
   PubMed Web of Science ®Google Scholar
• Grant WB. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 2011; 3:199 - 204; PMID: 22110780
   PubMedGoogle Scholar
• Robien K, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women’s Health Study. Cancer Causes Control 2007; 18:775 - 82; http://dx.doi.org/10.1007/s10552-007-9020-x; PMID: 17549593
   PubMed Web of Science ®Google Scholar
• Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009; 124:979 - 86; http://dx.doi.org/10.1002/ijc.23984; PMID: 19035445
   PubMed Web of Science ®Google Scholar
• Schöttker B, Ball D, Gellert C, Brenner H. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2012; http://dx.doi.org/10.1016/j.arr.2012.02.004; PMID: 22343489
   PubMed Web of Science ®Google Scholar
• Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011; 65:1016 - 26; http://dx.doi.org/10.1038/ejcn.2011.68; PMID: 21731036
   PubMed Web of Science ®Google Scholar
• Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95:91 - 100; http://dx.doi.org/10.3945/ajcn.111.014779; PMID: 22170374
   PubMed Web of Science ®Google Scholar
• Grant WB. An ecological study of cancer mortality rates in the United States with respect to solar ultraviolet-B doses, smoking, alcohol consumption and urban/rural residence. Dermatoendocrinol 2010; 2:68 - 76; http://dx.doi.org/10.4161/derm.2.2.13812; PMID: 21547102
   PubMedGoogle Scholar
• Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer 2006; 6:264; http://dx.doi.org/10.1186/1471-2407-6-264; PMID: 17096841
   PubMed Web of Science ®Google Scholar
• Chen W, Clements M, Rahman B, Zhang S, Qiao Y, Armstrong BK. Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control 2010; 21:1701 - 9; http://dx.doi.org/10.1007/s10552-010-9599-1; PMID: 20552265
   PubMed Web of Science ®Google Scholar
• Hartge P, Lim U, Freedman DM, Colt JS, Cerhan JR, Cozen W, et al. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006; 17:1045 - 52; http://dx.doi.org/10.1007/s10552-006-0040-8; PMID: 16933055
   PubMed Web of Science ®Google Scholar
• Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, et al, Interlymph Consortium. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008; 122:144 - 54; http://dx.doi.org/10.1002/ijc.23003; PMID: 17708556
   PubMed Web of Science ®Google Scholar
• Chang ET, Canchola AJ, Cockburn M, Lu Y, Wang SS, Bernstein L, et al. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. Blood 2011; 118:1591 - 9; http://dx.doi.org/10.1182/blood-2011-02-336065; PMID: 21622649
   PubMed Web of Science ®Google Scholar
• Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ, et al. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med 2012; 10:16; http://dx.doi.org/10.1186/1479-5876-10-16; PMID: 22284859
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Ng K, Bao Y, Kraft P, Stampfer MJ, Michaud DS, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2012; 21:82 - 91; http://dx.doi.org/10.1158/1055-9965.EPI-11-0836; PMID: 22086883
   PubMed Web of Science ®Google Scholar
• Toriola AT, Surcel HM, Calypse A, Grankvist K, Luostarinen T, Lukanova A, et al. Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study. Eur J Cancer 2010; 46:2799 - 805; http://dx.doi.org/10.1016/j.ejca.2010.05.019; PMID: 20601305
   PubMed Web of Science ®Google Scholar
• Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecol Oncol 2011; 121:369 - 75; http://dx.doi.org/10.1016/j.ygyno.2011.01.023; PMID: 21324518
   PubMed Web of Science ®Google Scholar
• McCullough ML, Bandera EV, Moore DF, Kushi LH. Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med 2008; 46:298 - 302; http://dx.doi.org/10.1016/j.ypmed.2007.11.010; PMID: 18155758
   PubMed Web of Science ®Google Scholar
• Negri E. Sun exposure, vitamin D, and risk of Hodgkin and non-Hodgkin lymphoma. Nutr Cancer 2010; 62:878 - 82; http://dx.doi.org/10.1080/01635581.2010.509535; PMID: 20924963
   PubMed Web of Science ®Google Scholar
• Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012; 33:159 - 71; http://dx.doi.org/10.1016/j.cct.2011.09.009; PMID: 21986389
   PubMed Web of Science ®Google Scholar
• Kristal AR. Are clinical trials the “gold standard” for cancer prevention research?. Cancer Epidemiol Biomarkers Prev 2008; 17:3289 - 91; http://dx.doi.org/10.1158/1055-9965.EPI-08-1066; PMID: 19064540
   PubMed Web of Science ®Google Scholar
• Lappe J, Heaney RP. Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol In press
   PubMedGoogle Scholar
• Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2010; 19:927 - 31; http://dx.doi.org/10.1158/1055-9965.EPI-09-1121; PMID: 20332255
   PubMed Web of Science ®Google Scholar
• Rejnmark L, Lauridsen AL, Brot C, Vestergaard P, Heickendorff L, Nexo E, et al. Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest 2006; 66:227 - 38; http://dx.doi.org/10.1080/00365510600570623; PMID: 16714251
   PubMed Web of Science ®Google Scholar
• Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, et al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 2000; 9:1059 - 65; PMID: 11045788
   PubMed Web of Science ®Google Scholar
• Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010; 171:903 - 8; http://dx.doi.org/10.1093/aje/kwq005; PMID: 20219763
   PubMed Web of Science ®Google Scholar
• Visser M, Deeg DJH, Puts MTE, Seidell JC, Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006; 84:616 - 22, quiz 671-2; PMID: 16960177
   PubMed Web of Science ®Google Scholar
• Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009; 71:666 - 72; http://dx.doi.org/10.1111/j.1365-2265.2009.03548.x; PMID: 19226272
   PubMed Web of Science ®Google Scholar
• Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010; 64:203 - 9; http://dx.doi.org/10.1038/ejcn.2009.140; PMID: 19953106
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Parimi N, Barrett-Connor E, Laughlin GA, Ensrud KE, Hoffman AR, et al, Osteoporotic Fractures in Men (MrOS) Research Group. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab 2010; 95:4625 - 34; http://dx.doi.org/10.1210/jc.2010-0638; PMID: 20631024
   PubMed Web of Science ®Google Scholar
• Jia X, Aucott LS, McNeill G. Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr 2007; 98:593 - 9; http://dx.doi.org/10.1017/S0007114507725163; PMID: 17442130
   PubMed Web of Science ®Google Scholar
• Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168:1629 - 37; http://dx.doi.org/10.1001/archinte.168.15.1629; PMID: 18695076
   PubMed Web of Science ®Google Scholar
• Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr 2011; 50:305 - 12; http://dx.doi.org/10.1007/s00394-010-0138-3; PMID: 20976461
   PubMed Web of Science ®Google Scholar
• Szulc P, Claustrat B, Delmas PD. Serum concentrations of 17β-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men--the MINOS study. Clin Endocrinol (Oxf) 2009; 71:594 - 602; http://dx.doi.org/10.1111/j.1365-2265.2009.03530.x; PMID: 19207314
   PubMed Web of Science ®Google Scholar
• Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol 2010; 162:935 - 42; http://dx.doi.org/10.1530/EJE-09-1041; PMID: 20185562
   PubMed Web of Science ®Google Scholar
• Michaëlsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundström J, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010; 92:841 - 8; http://dx.doi.org/10.3945/ajcn.2010.29749; PMID: 20720256
   PubMed Web of Science ®Google Scholar
• Bates CJ, Hamer M, Mishra GD. A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Osteoporos Int 2012; 23:457 - 66; http://dx.doi.org/10.1007/s00198-011-1543-z; PMID: 21380638
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011; 58:1433 - 41; http://dx.doi.org/10.1016/j.jacc.2011.03.069; PMID: 21939825
   PubMed Web of Science ®Google Scholar